000			02015 a2200541 4500
005			20250516015736.0
264		0	_c20110318
008			201103s 0 0 eng d
022			_a1872-7905
024	7		_a10.1016/j.jim.2010.12.007 _2doi
040			_aNLM _beng _cNLM
100	1		_aZuleger, Cindy L
245	0	0	_aIn vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells. _h[electronic resource]
260			_bJournal of immunological methods _cFeb 2011
300			_a76-86 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAmino Acid Motifs
650	0	4	_aAmino Acid Sequence
650	0	4	_aAntigens, Neoplasm _xgenetics
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aCase-Control Studies
650	0	4	_aCells, Cultured
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aGenes, T-Cell Receptor beta
650	0	4	_aHumans
650	0	4	_aHypoxanthine Phosphoribosyltransferase _xdeficiency
650	0	4	_aLymphocyte Activation
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMelanoma-Specific Antigens _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Sequence Data
650	0	4	_aMutation
650	0	4	_aReceptors, Antigen, T-Cell, alpha-beta _xgenetics
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aThioguanine _xpharmacology
700	1		_aMacklin, Michael D
700	1		_aBostwick, Bret L
700	1		_aPei, Qinglin
700	1		_aNewton, Michael A
700	1		_aAlbertini, Mark R
773	0		_tJournal of immunological methods _gvol. 365 _gno. 1-2 _gp. 76-86
856	4	0	_uhttps://doi.org/10.1016/j.jim.2010.12.007 _zAvailable from publisher's website
999			_c20470251 _d20470251